Frontlight ResearchEarly access
Myeloproliferative neoplasms trials in United States
118 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleAzacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Where
- Houston
- Age
- 18 years and over
- People
- 97
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04140487 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 1/2Taking peopleA Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Where
- Ann Arbor, Atlanta, Baltimore, Birmingham, Boston, Buffalo, Charleston, Charlottesville, Chicago, Columbus, Denver, Duarte, Durham, Gainesville, Hackensack, Houston, Los Angeles, Miami, Minneapolis, Nashville, New Haven, Newport Beach, New York, Salt Lake City, Seattle, St Louis, The Bronx, Tucson
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04176198 · EU 2022-502597-16-00 - Phase 2Not yet taking people in United StatesAutomated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
- Where
- Palo Alto
- Age
- 18 years to 70 years
- People
- 30
- Run by
- Stanford University
See details and how to joinNCT07634536 - No phaseNot yet taking people in United StatesWELL-MPN: A Digital Lifestyle App for Patients With MPNs
- Where
- Boston
- Age
- 18 years and over
- People
- 75
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT07349134 - Phase 2Taking peopleMetronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
- Where
- Richmond
- Age
- 18 years and over
- People
- 40
- Run by
- Virginia Commonwealth University
See details and how to joinNCT07710534 - Phase 1Taking peopleEdetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- Where
- Houston
- Age
- 1 year and over
- People
- 58
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03630991 - Phase 2Taking peopleDecitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
- Where
- Seattle
- Age
- 18 years and over
- People
- 25
- Run by
- University of Washington
See details and how to joinNCT04282187 - Phase 2Taking peopleHigh Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Where
- Houston
- Age
- 18 years to 75 years
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06345495 - Phase 2Taking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Atlanta, Birmingham, Boston, Charleston, Chicago, Cleveland, Duarte, Hialeah, Houston, Los Angeles, New York, Phoenix, Salt Lake City, Stanford
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - Phase 1/2Taking peopleIvosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- Where
- Boston, Cleveland, Houston, Portland
- Age
- 18 years and over
- People
- 96
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03471260 - Phase 1/2Taking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Duarte, Houston, Milwaukee, Pittsburgh, Tampa
- Age
- 18 years and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - No phaseTaking peopleA Telehealth Advance Care Planning Intervention
- Where
- Rochester
- Age
- 60 years and over
- People
- 207
- Run by
- University of Rochester
See details and how to joinNCT05875805 - Phase 1Taking peopleA Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
- Where
- Basking Ridge, Commack, East White Plains, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 18
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05714072 - Phase 1Taking peopleIvosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
- Where
- Chicago, Milwaukee
- Age
- 18 years and over
- People
- 18
- Run by
- University of Chicago
See details and how to joinNCT06291987 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bethesda, Bethlehem, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, Effingham, El Paso, Falls Church, Fargo, Flint, Fort Lauderdale, Fort Myers, Fort Sam Houston, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Mattoon, Maywood, McAllen, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Normal, Norton Shores, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reed City, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Traverse City, Tucson, Tulsa, Urbana, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester, Wyoming, Yorkville
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 2Taking peopleCPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04493164 - No phaseTaking peopleImproving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- Where
- Omaha
- Age
- 19 years and over
- People
- 114
- Run by
- University of Nebraska
See details and how to joinNCT04898790 - Phase 2Taking peoplePacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms
- Where
- Seattle
- Age
- 18 years and over
- People
- 27
- Run by
- University of Washington
See details and how to joinNCT07148947 - Phase 1Taking peopleThiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 48
- Run by
- Sawa Ito, MD
See details and how to joinNCT07565220 - Phase 1Taking peopleTACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
- Where
- Palo Alto
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Stanford University
See details and how to joinNCT07302776 - No phaseEnrolling by invitationPathogenesis of Hematologic Malignancies
- Where
- Portland
- Age
- 1 year and over
- People
- 5,000
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT01728402 - Phase 1Taking peopleA Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
- Where
- Austin, Baltimore, Chapel Hill, Chicago, Dallas, Denver, Jacksonville, Milwaukee, New York, Palo Alto, Phoenix, Salt Lake City
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07008118 - No phaseTaking peopleQuantitative MRI for Myelofibrosis
- Where
- Ann Arbor
- Age
- 18 years to 99 years
- People
- 192
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT01973881 - Phase 1/2Not yet taking people in United StatesRevumenib in Patients With Myelofibrosis
- Where
- New York
- Age
- 18 years and over
- People
- 32
- Run by
- John Mascarenhas
See details and how to joinNCT07734077